e-learning
resources
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
OMNIgene.SPUTUM suppresses contaminants while maintaining
Mycobacterium tuberculosis
viability and obviates cold-chain transport
Khalide Azam, Nureisha Cadir, Carla Madeira, Stephen H. Gillespie, Wilber Sabiiti
Source:
ERJ Open Res, 4 (1) 00074-2017; 10.1183/23120541.00074-2017
Journal Issue:
January
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Khalide Azam, Nureisha Cadir, Carla Madeira, Stephen H. Gillespie, Wilber Sabiiti. OMNIgene.SPUTUM suppresses contaminants while maintaining
Mycobacterium tuberculosis
viability and obviates cold-chain transport. ERJ Open Res, 4 (1) 00074-2017; 10.1183/23120541.00074-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Eosinophilic COPD
Related content which might interest you:
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture
Source: Eur Respir J 2007; 30: 501-507
Year: 2007
Mycobacterium tuberculosis blocks phagolysosome maturation in alveolar macrophages of tuberculosis patients
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Biological properties of Mycobacterium tuberculosis (Mtb) resistant to biocides
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021
Quantification of long term uptake and metabolism of isoniazid in patients treated for Mycobacterium tuberculosis infection
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
Key role of tuberculosis services funding mechanisms in tuberculosis control and elimination
Source: Eur Respir J 2015; 45: 289-291
Year: 2015
The effects of drug resistance phenotype on proliferation of
Mycobacterium tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004
Rapid resistance detection of
Mycobacterium tuberculosis
to second-line drugs using the manual mycobacterium growth indicator tube (MGIT) system.
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
Investigation of the inhibition of adherence of
Mycobacterium avium
complex (MAC) and
Mycobacterium tuberculosis
(MTB) to the respiratory mucosa
Source: Eur Respir J 2001; 18: Suppl. 33, 480s
Year: 2001
No human transmission of Mycobacterium malmoense in a perfect storm setting
Source: Eur Respir J 2012; 40: 1576-1578
Year: 2012
Standardization and quality control to determine the drug resistance of M. tuberculosis in Kazakhstan
Source: Eur Respir J 2002; 20: Suppl. 38, 358s
Year: 2002
Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis
Source: Eur Respir J 2010; 35: 692-694
Year: 2010
Accelerated analysis of reactivation of the dormant Mycobacterium tuberculosis using mycobacteriophage D29.
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Influence of glutoxim and its derivatives on the growth of
mycobacterium tuberculosis
(Mtb)
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
The main causes which are responsible for secondary chemoresistance of
Mycobacterium tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 524s
Year: 2003
Determination of drug susceptibility of
Mycobacterium tuberculosis
through mycolic acid analysis with HPLC technique - comparison to the conventional methods
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Defining optimal fluoroquinolone exposure against
Mycobacterium tuberculosis
: contribution of murine studies
Source: Eur Respir J, 57 (4) 2004315; 10.1183/13993003.04315-2020
Year: 2021
On the nature of Mycobacterium tuberculosis-latent bacilli
Source: Eur Respir J 2004; 24: 1044-1051
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept